Price target
11.750.000.00%
The 1 analyst offering 1 year price forecasts for RX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to RX in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RX EPS for the last quarter is 0.20 CAD despite the estimation of 0.14 CAD. In the next quarter EPS is expected to reach 0.15 CAD. Track more of BIOSYENT INC financials and stay on top of what is up with the company.
In the next quarter BIOSYENT INC revenue is expected to reach 9.10 M CAD. Check out BIOSYENT INC revenue and earnings and make informed decisions.
According to analysts, RX price target is 11.75 CAD with a max estimate of 11.75 CAD and a min estimate of 11.75 CAD. Check if this forecast comes true in a year, meanwhile watch BIOSYENT INC stock price chart and keep track of the current situation with RX news and stock market news.